CA-NETAPP
10.4.2024 19:01:45 CEST | Business Wire | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced an expansion of its partnership with Google Cloud to make it easier for organizations to leverage their data for generative AI (GenAI) and other hybrid cloud workloads. NetApp and Google Cloud are announcing the Flex service level for Google Cloud NetApp Volumes which supports storage volumes of nearly any size. NetApp is also releasing a preview of its GenAI toolkit reference architecture for retrieval-augmented generation (RAG) operations using Google Cloud Vertex AI platform.
More Flexible Data Storage Options for Google Cloud NetApp Volumes
Google Cloud and NetApp are announcing a new service level for NetApp Volumes called Flex that gives customers more granular control to adapt their storage and performance to match the exact needs of their cloud workloads.
“Increasing demand for data-intensive applications and insights has reinforced the need for a new approach to unified data storage that gives organizations the agility to move and store data wherever it is needed at any point in time,” said Pravjit Tiwana, Senior Vice President and General Manager, Cloud Storage at NetApp. “By extending our collaboration with Google Cloud, we’re delivering a flexible form factor that can be run on existing infrastructure across Google Cloud system without any tradeoffs to enterprise data management capabilities.”
With the addition of Flex, NetApp Volumes customers can choose from four service levels to leverage a fully managed file service built on NetApp ONTAPTM and operated by Google Cloud, including:
- Standard: highly available, general-purpose storage with advanced data management capabilities and 16MiB/sec per TiB of performance, which is recommended to support workloads such as file shares, virtual machines (VMs), and DevTest environments.
- Premium: highly available, high-performance storage with advanced data management capabilities and 64MiB/sec per TiB of performance, which is recommended for file shares, VMs, and databases.
- Extreme: highly available, low-latency, high-throughput storage with advanced data management capabilities and 128MiB/sec per TiB of performance, which is recommended for Online Transaction Processing (OLTP) high-performance databases and low-latency applications.
- Flex: highly available storage volumes with scalability from one GiB to 100TiB and up to one GiB/s of performance depending on the size of the underlying storage pool. This adaptable service level can support a wide variety of use cases, including AI.
“Google Cloud NetApp Volumes remains a critical component of every enterprise’s digital transformation strategy,” said Sameet Agarwal, GM/VP, Google Cloud Storage at Google Cloud. “Utilizing Google Cloud technologies, NetApp Volumes will power new capabilities that can improve how businesses operate and create real-world value for their organizations.”
The Flex service level will be generally available by Q2 2024 across 15 Google Cloud regions, expanding to the other Google Cloud regions by the end of 2024.
Unlocking Enterprise Data for Generative AI in Google Cloud
NetApp is also releasing a preview of its GenAI toolkit with support for NetApp Volumes. This offering, along with the accompanying reference architecture, speeds the implementation of RAG operations while enabling secure, consistent, and automated workflows that securely connect data stored in NetApp Volumes with Google Cloud Vertex AI platform. The result is a greater ability to generate unique, high-quality, and ultra-relevant insights and automations.
“As the intelligent data infrastructure company, we have unmatched capabilities to support data classification, tagging, mobility, and cloning for data wherever it lives so our customers can run efficient and secure AI data pipelines,” said Pravjit Tiwana, Senior Vice President and General Manager, Cloud Storage at NetApp. “Building on our partnership with Google Cloud to streamline RAG enables customers to tap into market-leading AI services and models to generate a unique competitive advantage.”
The NetApp GenAI toolkit helps optimize RAG processes with unique capabilities, including:
- Common data footprint everywhere: NetApp ONTAP allows customers to easily include data from any environment to power their RAG efforts with common operational processes while reducing risk, cost, and time to results.
- Automated classification and tagging: NetApp’s BlueXP classification service automatically tags data to support streamlined data cleansing for both the ingest and inferencing phases of the data pipeline, ensuring that the right data is used for queries and that sensitive data is not exposed to the model out of policy.
- Fast, scalable snapshots: ONTAP Snapshot delivers near-instant creation of space-efficient, in-place copies of vector stores and databases, allowing immediate roll back to a previous version if data is corrupted or forward if point-in-time analysis is needed.
- Real-time cloning at scale: ONTAP FlexClone technology can create instant clones of vector index stores to safely make uniquely relevant data instantly available for different queries for different users, without impacting the core production data.
“GenAI is a tidal wave of opportunity for the companies that can effectively apply their data to their industry,” said Miles Ward, CTO at SADA, An Insight Company. “At SADA we are fired up about pairing our extensive expertise with NetApp and Vertex AI to help customers accelerate their AI journeys. Why generate uninformed chats when you could generate unique, specific, relevant insights?”
The GenAI toolkit will be available as a public preview within the second half of 2024.
To learn more about the Flex service level for NetApp Volumes or the GenAI toolkit reference architecture for Vertex AI, visit the NetApp booth #1231 at the Google Cloud Next 2024 conference running from April 9-11 at Mandalay Bay in Las Vegas.
Additional Resources
- All Your Datasets are Welcome on Google Cloud NetApp Volumes. Did We Say No Trade-Offs?
- Introducing Google Cloud NetApp Volumes Flex Service Level
- Google Cloud NetApp Volumes
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240410415954/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom